Cognitive-enhancing drugs in the healthy population: Fundamental drawbacks and researcher roles
The use of pharmacological cognitive enhancers (PCEs) in the healthy population is a controversial topic with numerous and expansive repercussions. By outlining common proponent arguments on the current PCE state of affairs, the definition of normality, and the complex regulation of PCEs, this ar...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cogent OA
2015
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/38460/ http://eprints.usm.my/38460/1/Cognitive-enhancing_drugs_in_the_healthy_population_Fundamental_drawbacks.pdf |
| Summary: | The use of pharmacological cognitive enhancers (PCEs) in the healthy
population is a controversial topic with numerous and expansive repercussions. By
outlining common proponent arguments on the current PCE state of affairs, the
definition of normality, and the complex regulation of PCEs, this article addresses
why the mainstream use of PCEs in the healthy population is still disadvantageous
overall. In this respect, the influence and roles of researchers to the society are
emphasized in bringing the focus back to the fundamental issues, which is crucial
in deciphering its controversy and avoiding costly societal, research credibility and
ethical implications. |
|---|